tiprankstipranks
BioAtla downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyBioAtla downgraded to Neutral from Buy at H.C. Wainwright
3M ago
BioAtla Reports Q3 2024 Financial Results and Clinical Advances
Premium
Company Announcements
BioAtla Reports Q3 2024 Financial Results and Clinical Advances
4M ago
BioAtla reports Q3 EPS (22c), consensus (36c)
Premium
The Fly
BioAtla reports Q3 EPS (22c), consensus (36c)
4M ago
These 2 “Strong Buy” Penny Stocks Are Poised for a Big Rally, Say Analysts
PremiumStock Analysis & IdeasThese 2 “Strong Buy” Penny Stocks Are Poised for a Big Rally, Say Analysts
7M ago
BioAtla to hold an analyst research and development day
Premium
The Fly
BioAtla to hold an analyst research and development day
7M ago
BioAtla granted FDA FTD for ozuriftamab vedotin
Premium
The Fly
BioAtla granted FDA FTD for ozuriftamab vedotin
7M ago
BioAtla price target lowered to $7 from $10 at H.C. Wainwright
PremiumThe FlyBioAtla price target lowered to $7 from $10 at H.C. Wainwright
11M ago
BioAtla reports Q4 revenue $7.8M vs $5.8M last year
Premium
The Fly
BioAtla reports Q4 revenue $7.8M vs $5.8M last year
11M ago
BioAtla reports Q4 net loss $26.9M  vs. $27.6M last year
Premium
The Fly
BioAtla reports Q4 net loss $26.9M vs. $27.6M last year
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100